Bioalpha signs health supplement manufacturing deal with Ritamix

KUALA LUMPUR: Bioalpha Holdings Bhd's subsdiary Bioalpha International Sdn Bhd has entered into a collaborative agreement with Ritamix Global Ltd for the manufacture and supply of health supplement products.

The group said in a filing with Bursa Malaysia on Wednesday Hong Kong-based Ritamix will market the products in China and Southeast Asia.

"Pursuant to the agreement, BISB will act as the contract manufacturer for Ritamix in the development of health supplement products not limited to immunity and longevity products.

"The products are formulated and owned by Ritamix," it said.

Ritamix is listed on the main market of the Hong Kong Stock Exchange, and is principally engaged in the distribution of animal feed additives and, to a lesser extent, human food ingredients, and the manufacturing of animal feed premixes.

Bioalpha was the second most actively traded stock on Bursa Malaysia today with 257.12 million shares traded. At the midday break it was up one sen to 36.5 sen a share.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Bioalpha , Ritamix , health supplement


Did you find this article insightful?


67% readers found this article insightful

Next In Business News

US says Vietnam's currency actions 'unreasonable' but holds off on tariffs
Top Glove reports Covid-19 outbreak at four factories
AmBank provides 6-month moratorium for flood victims
Principal Asset launches Next-G connectivity fund
CPO futures to trend lower on profit taking next week
WhatsApp to delay launch of update business features
US National Rifle Association files for bankruptcy
Oil drops over 2% on China lockdowns, U.S. stimulus concerns
Dollar finishes week stronger as US data hurts risk appetite
GLOBAL MARKETS-Data, lockdowns weigh on stocks

Stories You'll Enjoy